MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development
Bilal N Sheikh, Stanley CW Lee, Farrah El-Saafin, Hannah K Vanyai, Yifang Hu, Swee Heng Milon Pang, Stephanie Grabow, Andreas Strasser, Stephen L Nutt, Warren S Alexander, Gordon K Smyth, Anne K Voss, Tim Thomas
Blood | AMER SOC HEMATOLOGY | Published : 2015
Awarded by National Health and Medical Research Council (NHMRC)
Awarded by NHMRC program
Awarded by NHMRC
Awarded by Leukemia and Lymphoma Society
This study was funded by grants from the National Health and Medical Research Council (NHMRC) project (1030704, 1008699, and 1010851), the NHMRC program (1054618, 1016647, and 1016701), NHMRC research fellowships (1058892) (G.K.S.), (1058344) (W.S.A.), (1003435) (T.T.), (575512) (A.K.V.), and (1020363) (A.S.), Lady Tata Research Award (S.G.), Cancer Council Victoria postdoctoral fellowship (S.G.), Leukemia and Lymphoma Society (SCOR grant 7001-13) (A.S.), Australian Research Council future fellowship (S.L.N.), Independent Research Institutes Infrastructure Support Scheme from the Australian Government's NHMRC, the Australia Cancer Research Fund, and the Victorian State Government Operational Infrastructure Support.